ArticleInternational journal of molecular sciences2025
Pentagalloylglucose Inhibits Melanogenesis via Suppression of MITF Signaling Pathway.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Targeting MAPK Pathways in Skin, Thyroid, and Pancreatic Cancer: A Perspective on Synthetic Inhibitors and Natural Modulators.Advanced biology · 2026Review
- Isolation and Anti-Melanogenic Activity of Polycarpol fromJournal of fungi (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pentagalloylglucose (PGG) is a powerful antioxidant and a naturally derived polyphenolic compound present in tannins. In this study, we investigated the ability of PGG to selectively inhibit hyperpigmentation through the regulation of melanogenesis in melanocytes. PGG inhibited melanin production in α-melanocyte-stimulating hormone (α-MSH)-induced B16F10 melanoma cells. Furthermore, PGG suppressed the expression of melanin synthesis enzymes, such as tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2. The mRNA and protein expression of the microphthalmia-associated transcription factor, which is involved in the mechanism of melanogenesis, was also reduced by PGG, and this effect was induced via PKA/CREB and MAPK phosphorylation. These results suggest that PGG inhibits α-MSH-induced melanin production by regulating the PKA/CREB/MAPK signaling pathway, indicating that natural compounds can serve as inhibitors of melanogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.